Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
OrbusNeich Medical Group Holdings Limited ( (HK:6929) ) has issued an update.
OrbusNeich Medical Group Holdings Limited announced that Dr. Zhou Yi has resigned as a non-executive director of the company, effective 22 January 2026, citing a need to devote more time to other business commitments. The board noted that Dr. Zhou has no disagreements with the board and that there are no matters related to his departure requiring shareholder or regulatory attention, while expressing gratitude for his contributions; following his resignation, the board will consist of three executive directors, one non-executive director and three independent non-executive directors, maintaining its existing governance structure.
The most recent analyst rating on (HK:6929) stock is a Hold with a HK$4.00 price target. To see the full list of analyst forecasts on OrbusNeich Medical Group Holdings Limited stock, see the HK:6929 Stock Forecast page.
More about OrbusNeich Medical Group Holdings Limited
OrbusNeich Medical Group Holdings Limited is a Hong Kong-listed medical device company focused on cardiovascular interventions. The group develops and markets interventional products used in cardiology and related medical procedures, serving hospitals and clinicians in key global healthcare markets.
Average Trading Volume: 139,479
Technical Sentiment Signal: Sell
Current Market Cap: HK$3.19B
Learn more about 6929 stock on TipRanks’ Stock Analysis page.